Kevin F. Murphy

Array ( [id] => 3067460 [patent_doc_number] => 05352782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Process for preparing crystalline .beta.-lactam monohydrate' [patent_app_type] => 1 [patent_app_number] => 8/071552 [patent_app_country] => US [patent_app_date] => 1993-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2457 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352782.pdf [firstpage_image] =>[orig_patent_app_number] => 071552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3480868 [patent_doc_number] => 05399686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-21 [patent_title] => 'Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate' [patent_app_type] => 1 [patent_app_number] => 8/072204 [patent_app_country] => US [patent_app_date] => 1993-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1830 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/399/05399686.pdf [firstpage_image] =>[orig_patent_app_number] => 072204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3463218 [patent_doc_number] => 05391729 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-21 [patent_title] => 'Crystalline dihydrate of a cephalosporin salt' [patent_app_type] => 1 [patent_app_number] => 8/071029 [patent_app_country] => US [patent_app_date] => 1993-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7874 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/391/05391729.pdf [firstpage_image] =>[orig_patent_app_number] => 071029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3458581 [patent_doc_number] => 05401841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-28 [patent_title] => 'Process for the production of cephalosporines' [patent_app_type] => 1 [patent_app_number] => 8/069239 [patent_app_country] => US [patent_app_date] => 1993-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4706 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/401/05401841.pdf [firstpage_image] =>[orig_patent_app_number] => 069239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3007620 [patent_doc_number] => 05374739 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-20 [patent_title] => 'Mitomycin analogs' [patent_app_type] => 1 [patent_app_number] => 8/068833 [patent_app_country] => US [patent_app_date] => 1993-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4250 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/374/05374739.pdf [firstpage_image] =>[orig_patent_app_number] => 068833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3613694 [patent_doc_number] => 05510318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Herbicidal oxazine ethers' [patent_app_type] => 1 [patent_app_number] => 8/064004 [patent_app_country] => US [patent_app_date] => 1993-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27581 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 332 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510318.pdf [firstpage_image] =>[orig_patent_app_number] => 064004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456956 [patent_doc_number] => 05401734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-28 [patent_title] => 'Cephem compounds' [patent_app_type] => 1 [patent_app_number] => 8/063982 [patent_app_country] => US [patent_app_date] => 1993-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18659 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/401/05401734.pdf [firstpage_image] =>[orig_patent_app_number] => 063982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3116817 [patent_doc_number] => 05410042 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-25 [patent_title] => 'Process for the cleavage of cephalosporin prodrug esters to 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid' [patent_app_type] => 1 [patent_app_number] => 8/063574 [patent_app_country] => US [patent_app_date] => 1993-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2175 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/410/05410042.pdf [firstpage_image] =>[orig_patent_app_number] => 063574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3498466 [patent_doc_number] => 05532353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Process for the preparation of halogenated .beta.-lactam compounds' [patent_app_type] => 1 [patent_app_number] => 8/058714 [patent_app_country] => US [patent_app_date] => 1993-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4359 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 278 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532353.pdf [firstpage_image] =>[orig_patent_app_number] => 058714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3569402 [patent_doc_number] => 05484928 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => '2-(2-aminothiazol-4-yl)-2-oxoacetic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 8/055613 [patent_app_country] => US [patent_app_date] => 1993-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9410 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484928.pdf [firstpage_image] =>[orig_patent_app_number] => 055613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3480777 [patent_doc_number] => 05399679 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-21 [patent_title] => '(1\'R,3S,4R)4-acylthio azetidinones' [patent_app_type] => 1 [patent_app_number] => 8/054233 [patent_app_country] => US [patent_app_date] => 1993-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3298 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/399/05399679.pdf [firstpage_image] =>[orig_patent_app_number] => 054233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3087834 [patent_doc_number] => RE034935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-09 [patent_title] => 'Method for preparing (+)-(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-5H-1,5-benzothiaze pine-4-one and chlorinated derivatives thereof' [patent_app_type] => 2 [patent_app_number] => 8/053855 [patent_app_country] => US [patent_app_date] => 1993-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1497 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/034/RE034935.pdf [firstpage_image] =>[orig_patent_app_number] => 053855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3107184 [patent_doc_number] => 05418226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-23 [patent_title] => 'Monoquaternary 2,16-bispiperidinylandrostane derivatives' [patent_app_type] => 1 [patent_app_number] => 8/048539 [patent_app_country] => US [patent_app_date] => 1993-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2307 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/418/05418226.pdf [firstpage_image] =>[orig_patent_app_number] => 048539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3114430 [patent_doc_number] => 05409919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-25 [patent_title] => 'Pharmaceutically acceptable salt of 7B-[2-(5-amino-1,2,4-thio-diazol-3-yl)-2(Z)-metho-xyiminoacetamido]-3-[( imidazo[1,2-b]pyridazinium-1-yl)methyl]-3-cephem-4-carboxylate and composition comprising same' [patent_app_type] => 1 [patent_app_number] => 8/041849 [patent_app_country] => US [patent_app_date] => 1993-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30818 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/409/05409919.pdf [firstpage_image] =>[orig_patent_app_number] => 041849 [rel_patent_id] =>[rel_patent_doc_number] =>)